Maxwell Biomedical
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.maxwellbiomedical.comRevenue
<$5 MillionIndustry
About Maxwell Biomedical
MaxWell Biomedical specializes in innovative therapies for atrial fibrillation, particularly through their advanced Rhythm360 platform. Their flagship product, Cardiac Resynchronization Therapy for the Atrium (CRT-A), aims to restore both sinus rhythm and atrial mechanical function in patients suffering from atrial fibrillation and heart failure. The company targets healthcare providers and clinicians seeking effective, non-destructive treatment options for patients inadequately served by existing therapies. With a focus on improving long-term outcomes, MaxWell Biomedical is pioneering a new approach to atrial dysfunction and rhythm disorders.Explore more
SIC Code 38,382NAICS Code 33,339Show moreMaxwell Biomedical Org Chart
Compare Similar Companies to Maxwell Biomedical
Compare insights from companies similar to Maxwell Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Maxwell Biomedical Tech Stack
A closer look at the technologies used by Maxwell Biomedical
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Maxwell Biomedical
Sign Up For FreeTo access detailed company insights
MaxWell Biomedical specializes in innovative therapies for atrial fibrillation, particularly through their advanced Rhythm360 platform. Their flagship product, Cardiac Resynchronization Therapy for the Atrium (CRT-A), aims to restore both sinus rhythm and atrial mechanical function in patients suffering from atrial fibrillation and heart failure. T... Read More